NCT00000568View on ClinicalTrials.gov

Lung Health Study (LHS) I and III

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 1984

Study Completion Date

January 31, 2005

Conditions

Lung DiseasesLung Diseases, ObstructiveChronic Obstructive Pulmonary Disease

Interventions

BEHAVIORAL

smoking cessation

DRUG

ipratropium

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000568 - Lung Health Study (LHS) I and III | Biotech Hunter | Biotech Hunter